News News

Back

euCanSHAre: A new H2020 project coordinated by UPF on the topic big data and data sharing for personalised medicine research in cardiology

euCanSHAre: A new H2020 project coordinated by UPF on the topic big data and data sharing for personalised medicine research in cardiology

Coordinated by Karim Lekadir from the SIMBIOsys research group, will develop the first centralised, secure and sustainable platform for enhanced cross-border data sharing and multi-study personalised medicine research in cardiology.

04.12.2018

 

The euCanSHare project, coordinated by Karim Lekadir from the SIMBIOsys research group, will develop the first centralised, secure and sustainable platform for enhanced cross-border data sharing and multi-study personalised medicine research in cardiology.

The project will start on 1st Decemebr 2018, with a duration of 4 years and a total funding of over 6 M€. euCanSHare will have its kick-off meeting in Brussels, at the European Society of Cardiology, on 11 December 2018.

The first centralised, secure and sustainable platform for enhanced cross-border data sharing and multi-study personalised medicine research in cardiology

Initially populated with 35 European and Canadian cohorts totalling over one million records, the platform will include extensive functionalities for data deposition, data harmonisation and data analysis. The features of the platform will be demonstrated and adjusted through several use cases, including for investigating diabetic cardiomyopathy, myocardial infarction and stroke using multi-factorial and multi-omics integrative approaches.

The data analysis module of the platform will offer tools for cardiac image segmentation, cardiac quantification, and data quality control, as well as bioinformatics and machine learning capabilities.

A project coordinated by the UPF

In this project, UPF will coordinate a highly experienced and multi-disciplinary consortium that includes 11 European research institutions, two European organisations, two European SMEs and three Canadian institutions. Among the research institutions, the Barcelona Supercomputing Center (BSC) and the Center for Genomic Regulation (CRG) are involved.

Consortium:

  • Universitat Pompeu Fabra, Barcelona, Spain (coordinator)
  • Medical University of Hamburg-Eppendorf, Hamburg, Germany
  • Erasmus Medical Centre Rotterdam, Netherlands
  • Queen Mary University of London, UK
  • Katholieke Universiteit Leuven, Belgium
  • Barcelona Supercomputing Centre, Spain
  • Centre for Genomic Regulation, Barcelona, Spain
  • National Institute for Health and Welfare, Finland
  • Medical University of Greifswald, Germany
  • European Society of Cardiology, Sophia Antipolis, France
  • Biobanking and Biomolecular Resources Research Infrastructure, Vienna, Austria
  • Lynkeus Srl, Roma, Italy (SME)
  • Nostrum BioDiscovery, Barcelona, Spain (SME)
  • Research Institute of the McGill University Health Centre, Montreal, Canada
  • McGill University, Montreal, Canada
  • McMaster University, Hamilton Health Sciences, Canada

Multimèdia

Multimedia

Multimedia

Categories:


UPF in action UPF in action

Highlights Highlights

Why UPF?

UPF in figures

27 bachelor's degrees
33 master's degrees
9 doctorates
91 % of UPF graduates would choose the same university again
28 degree's programmes offered in English (undergraduate, master's and doctorate)
44 % of master's and doctoral students are international
26 % if international teaching staff
390 international agreements
30 % of UPF graduates found a job through the University
1240 companies for internship agreements
20 economic grants for development cooperation projects
9900 euros donated by UPF students allocated for grants and solidarity projects

Agenda Agenda